<\/p>\n
A total of 13 companies filed for IPO over the past seven days and five have set terms to debut next week.<\/p>\n
NEW FILINGS<\/p>\n
Company: Leslie\u2019s, Inc.
\nSymbol: LESL
\nDescription: They are the largest and most trusted direct-to-consumer brand in the nearly $11 billion United States pool and spa care industry, serving residential, professional, and commercial consumers.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Goldman Sachs, Morgan Stanley, BofA Securities
\nFiled: 10-7-20
\nListed Cash Raise: $100m<\/p>\n
Company: Galecto, Inc.
\nSymbol: GLTO
\nDescription: They are a clinical-stage biotechnology company developing therapeutics that are designed to target the biological processes that lie at the heart of fibrosis and impact a broad range of fibrotic and related diseases, including cancer.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): BofA Securities, SVB Leerink, Credit Suisse
\nFiled: 10-7-20
\nListed Cash Raise: $100m<\/p>\n
Company: Lufax Holding Ltd
\nSymbol: LU
\nDescription: They are a leading technology-empowered personal financial services platform in China.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Goldman Sachs, BofA Securities, UBS Investment Bank, HSBC, China PA Securities (Hong Kong) Company Limited, Morgan Stanley, CLSA. Jefferies
\nFiled: 10-7-20
\nListed Cash Raise: $100m<\/p>\n
Company: Mavenir plc
\nSymbol: MVNR
\nDescription: They provide software to drive the digital transformation of mobile networks. Our suite of cloud-native software applications delivers the critical network functionality that allows Wireless Service Providers to meet the needs of their enterprise and consumer customers.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Morgan Stanley, Goldman Sachs, J.P. Morgan, BofA Securities, Barclays, Guggenheim Securities, Macquarie Capital
\nFiled: 10-7-20
\nListed Cash Raise: $100m<\/p>\n
Company: Allegro MicroSystems, Inc.
\nSymbol: ALGM
\nDescription: Allegro MicroSystems is a leading global designer, developer, fabless manufacturer and marketer of sensor ICs and application-specific analog power ICs enabling the most important emerging technologies in the automotive and industrial markets.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Barclays, Credit Suisse, Wells Fargo
\nCo-Manager(s): Jefferies, Mizuho Securities, Needham, SMBC Nikko
\nFiled: 10-6-20
\nListed Cash Raise: $100m<\/p>\n
Company: Telos Corporation.
\nSymbol: TLS
\nDescription: Telos Corporation offers technologically advanced, software-based security solutions that empower and protect the world\u2019s most security-conscious organizations against rapidly evolving, sophisticated and pervasive threats..
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): B. Riley Securities, BMO Capital Markets, Needham & Company
\nFiled: 10-6-20
\nListed Cash Raise: $241.5m<\/p>\n
Company: MediaAlpha, Inc.
\nSymbol: MAX
\nDescription: Their mission is to help insurance carriers and distributors target and acquire customers more efficiently and at greater scale through technology and data science.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): J.P. Morgan, Citigroup, Credit Suisse, RBC Capital Markets, Canaccord Genuity, William Blair
\nCo-Manager(s): MUFG
\nFiled: 10-5-20
\nListed Cash Raise: $100m<\/p>\n
Company: Root, Inc.
\nSymbol: ROOT
\nDescription: Root is a technology company revolutionizing personal insurance with a pricing model based upon fairness and a modern customer experience.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Goldman Sachs, Morgan Stanley, Barclays, Wells Fargo Securities, Credit Suisse, Deutsche Bank Securities ,Evercore ISI, Truist Securities
\nCo-Manager(s): Cantor, JMP Securities, Siebert Williams Shank
\nFiled: 10-5-20
\nListed Cash Raise: $100m<\/p>\n
Company: Aspire Real Estate Investors, Inc.
\nSymbol: TBD
\nDescription: They will be externally managed and advised by our Manager, which is majority owned and controlled by an affiliate of Avanath, a real estate investment manager that invests in property markets nationwide on behalf of pension funds and other institutional investors through commingled funds.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Morgan Stanley, B. Riley Securities, Wells Fargo Securities, BMO Capital Markets, KeyBanc Capital Markets
\nFiled: 10-2-20
\nListed Cash Raise: $100m<\/p>\n
Company: Abcam plc
\nSymbol: ABCM
\nDescription: They are a global life science company focused on identifying, developing and distributing high-quality reagents and tools for our customers at the forefront of life science research. Their ordinary shares trade on AIM, a market of the London Stock Exchange, under the symbol \u201cABC.\u201d
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Morgan Stanley, BofA Securities, SVB Leerink
\nCo-Manager(s): Lazard, William Blair
\nFiled: 10-2-20
\nListed Cash Raise: $100m<\/p>\n
Company: Foghorn Therapeutics Inc.
\nSymbol: FHTX
\nDescription: They are pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, an untapped opportunity for therapeutic intervention.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Goldman Sachs, Morgan Stanley, Cowen
\nCo-Manager: Wedbush PacGrow
\nFiled: 10-2-20
\nListed Cash Raise: $100m<\/p>\n
Company: Caliber Home Loans, Inc.
\nSymbol: HOMS
\nDescription: They are a proven leader in the U.S. mortgage market with a uniquely diversified, customer-centric, purchase-focused platform.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Credit Suisse, Goldman Sachs, Barclays
\nFiled: 10-2-20
\nListed Cash Raise: $100m<\/p>\n
Company: Biodesix, Inc.
\nSymbol: BDSX
\nDescription: They are a leading data-driven diagnostic solutions company leveraging state of the art technologies with our proprietary artificial intelligence (AI) platform to discover, develop, and commercialize solutions for clinical unmet needs, with a primary focus in lung disease.
\nShares: TBD
\nPrice Range: TBD
\nTrade Date: TBD
\nUnderwriter(s): Morgan Stanley, William Blair
\nCo-Manager(s): Canaccord Genuity, BTIG
\nFiled: 10-2-20
\nListed Cash Raise: $75m<\/p>\n
UPDATED TERMS<\/p>\n
Company: Codiak BioSciences, Inc.
\nSymbol: CDAK
\nDescription: They are a development-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics, a new class of medicines with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need.
\nShares: 5.5 million
\nPrice Range: $14.00-$16.00
\nMarket Cap: $260m-$298m
\nTrade Date: Wednesday, 10\/14
\nUnderwriter(s): Goldman Sachs, Evercore ISI, William Blair
\nCo-Manager: Wedbush PacGrow
\nTerms Added: 10-7-20
\nNote: First Filed in April 2019<\/p>\n
Company: Array Technologies, Inc.
\nSymbol: ARRY
\nDescription: They are one of the world\u2019s largest manufacturers of ground-mounting systems used in solar energy projects.
\nShares: 33.75 million
\nPrice Range: $19.00-$21.00
\nMarket Cap: $2.4b-$2.7b
\nTrade Date: Thursday, 10\/15
\nUnderwriter(s): Goldman Sachs, J.P. Morgan, Guggenheim Securities, Morgan Stanley, Credit Suisse, Barclays, UBS Investment Bank
\nCo-Manager(s): Cowen, Oppenheimer, MUFG, Nomura
\nTerms Added: 10-7-20<\/p>\n
Company: MINISO Group Holding Limited
\nSymbol: MNSO
\nDescription: They are a fast-growing global value retailer offering a variety of design-led lifestyle products.
\nShares: 30.4 million
\nPrice Range: $16.50-$18.50
\nMarket Cap: $5.0b-$5.6b
\nTrade Date: Week of 10\/12
\nUnderwriter(s): Goldman Sachs, BofA Securities
\nTerms Added: 10-7-20
\nListed Cash Raise: $100m<\/p>\n
Company: Spinal Elements Holdings, Inc.
\nSymbol: SPEL
\nDescription: They are a medical device company focused on the design, development and commercialization of a comprehensive portfolio of systems, products and technologies for spine surgery procedures, with a strategic focus on minimally invasive surgery (\u201cMIS\u201d) procedures.
\nShares: 7.7 million
\nPrice Range: $13.00-$15.00
\nMarket Cap: $353m-$407m
\nTrade Date: Thursday, 10\/15
\nUnderwriter(s): Credit Suisse, Baird, Stifel
\nCo-Manager(s): Truist Securities, BTIG, Siebert Williams Shank
\nTerms Added: 10-8-20<\/p>\n
Company: Praxis Precision Medicines, Inc.
\nSymbol: PRAX
\nDescription: They are a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system, or CNS, disorders characterized by neuronal imbalance.
\nShares: 7.4 million
\nPrice Range: $16.00-$18.00
\nMarket Cap: $546m-$615m
\nTrade Date: Friday, 10\/16
\nUnderwriter(s): Cowen, Evercore ISI, Piper Sandler
\nCo-Manager(s): Wedbush PacGrow, Blackstone Capital
\nTerms Added: 10-9-20<\/p>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":4,"featured_media":12986,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[2058,1536],"tags":[],"class_list":["post-15423","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-spotlight","category-subscriber-content"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/15423","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=15423"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/15423\/revisions"}],"predecessor-version":[{"id":15424,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/15423\/revisions\/15424"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media\/12986"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=15423"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=15423"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=15423"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}